Our top pick for
Beginners
Finder Award
Atai Life Sciences, a Peter Thiel-backed company that produces psychedelic and non-psychedelic mushroom-based therapies for depression and anxiety, is expected to go public. We'll update this page as new information emerges.
How to buy shares in ATAI Life Sciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ATAI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
ATAI Life Sciences stock price (NASDAQ: ATAI)
Use our graph to track the performance of ATAI stocks over time.ATAI Life Sciences shares at a glance
Information last updated 2022-06-24.
| Latest market close | $3.68 |
|---|---|
| 52-week range | $2.95 - $20.45 |
| 50-day moving average | $3.97 |
| 200-day moving average | $8.06 |
| Wall St. target price | $25.92 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.40 |
Buy ATAI Life Sciences shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 6 of 6
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ATAI Life Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ATAI Life Sciences price performance over time
Historical closes compared with the close of $3.68 from 2022-06-29
| 1 week (2022-06-23) | 0.82% |
|---|---|
| 1 month (2022-05-26) | N/A |
| 3 months (2022-03-30) | -31.09% |
| 6 months (2021-12-30) | -49.93% |
| 1 year (2021-06-30) | -80.11% |
|---|---|
| 2 years (2020-06-26) | N/A |
| 3 years (2019-06-26) | N/A |
| 5 years (2017-06-26) | N/A |
ATAI Life Sciences financials
| Revenue TTM | $496,000 |
|---|---|
| Gross profit TTM | $20.4 million |
| Return on assets TTM | -37.52% |
| Return on equity TTM | -91.01% |
| Profit margin | 0% |
| Book value | $2.15 |
| Market capitalisation | $609.2 million |
TTM: trailing 12 months
ATAI Life Sciences share dividends
We're not expecting ATAI Life Sciences to pay a dividend over the next 12 months.
ATAI Life Sciences overview
Atai Life Sciences N. V. , through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder; RLS-01, a formulation of Salvinorin A for TRD; KUR-101, an oral formulation of deuterated mitragynine to treat OUD; and DMX-1001, an oral formulation of noribogaine for the treatment of OUD. The company was formerly known as Adripa Holding B.
Frequently asked questions
What percentage of ATAI Life Sciences is owned by insiders or institutions?Currently 9.413% of ATAI Life Sciences shares are held by insiders and 28.876% by institutions. How many people work for ATAI Life Sciences?
Latest data suggests 87 work at ATAI Life Sciences. When does the fiscal year end for ATAI Life Sciences?
ATAI Life Sciences's fiscal year ends in December. Where is ATAI Life Sciences based?
ATAI Life Sciences's address is: Krausenstrasse 9-10, Berlin, Germany, 10117 What is ATAI Life Sciences's ISIN number?
ATAI Life Sciences's international securities identification number is: NL0015000DX5
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert